What does TTT stand for?

Transpupillary Thermotherapy

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Tongue-Tied Terror Total Time on Test Total Time on Test (reliability) Touch Tone Terrorists Track Type Tracker Train The Trainer Training Task Table Transition to Track (radar) Transition Town Totnes (UK) Transpennine Topology Triangle (seminar; UK)		Trappentreuthtunnel (Munich, Germany tunnel) Triangle Tennis Trust (Chennai, India) Tried & True Trains (model railroading) Trinidad and Tobago Television Trunk-to-Trunk Transfer Truth Takes Time Tummy Touching Table Turbo Tax Timmy (Timothy Geithner) Turning the Tides (band; Pennsylvania) Tut-Tera Teksajo (Esperanto: WWW)

Samples in periodicals archive:

One of these AMD presentations used our IRIS Medical OcuLight(R) infrared laser system to treat occult sub-foveal wet AMD in a procedure called Transpupillary ThermoTherapy (TTT).

IRIDEX REPORTS 8% SALES INCREASE FOR 2ND QUARTER

Nasdaq:IRIX) announced the publication of two additional clinical studies using the Company's IRIS Medical(R) OcuLight(R) SLx laser that further validate the effectiveness of transpupillary thermotherapy (TTT) for the treatment of wet age-related macular degeneration (AMD).

IRIDEX -- Two More Clinical Studies Published -- Validate the ...

BUSINESS WIRE)--April 22, 2003 IRIDEX Corporation (Nasdaq:IRIX) announced that Medicare will begin to cover transpupillary thermotherapy (TTT) and feeder vessel (FV) laser protocols to treat wet age-related macular degeneration (AMD) in the state of California.

IRIDEX Announces Laser Treatments of Wet AMD Approved for Medicare ...

16, 2001 IRIDEX Corporation (Nasdaq:IRIX) announced today that Noridian Mutual Insurance, a Medicare Part B Carrier, published that it will begin to cover transpupillary thermotherapy (TTT) procedures administered to treat choroidal neovascularization (CNV) secondary to wet age-related macular degeneration (AMD) effective for dates of service on or after May 1, 2001.

IRIDEX Corporation Announces: TTT Treatment of Wet AMD Receives ...

30, 2001--IRIDEX Corporation (NASDAQ/NMS:IRIX) announced positive results from a recently published study(1) performed at King's College Hospital in London, England using an IRIDEX OcuLight(R) laser to assess the efficacy of transpupillary thermotherapy (TTT) photocoagulation for the treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).

IRIDEX Announces Results of a New Study That Further Validate ...

14, 2000 IRIDEX Corporation (NASDAQ/NMS:IRIX) announced that results from two clinical studies, one performed in Japan and a second performed in the USA, provide additional validation of successful outcomes following Transpupillary Thermotherapy (TTT) treatment of subfoveal occult wet age-related macular degeneration (AMD).

IRIDEX Reports Two Clinical Studies Further Validate TTT Treatment of ...

The study used Transpupillary Thermotherapy (TTT) photocoagulation to treat patients with subfoveal occult wet AMD.

IRIDEX Announces Positive Study Results for the Treatment of Occult ...

AMD procedures that use the IRIDEX IRIS Medical(R) OcuLight(R) infrared laser, such as transpupillary thermotherapy (TTT), destruction of macular drusen, and feeder vessel technique, can now be submitted to Medicare for reimbursement.

IRIDEX AMD Procedures Can be Submitted for Medicare Reimbursement